Fresenius Renews Bid To Stay Damages Trial
Fresenius Medical Care has lashed out at Baxter International Inc. for arguing against Fresenius' bid to stay a second damages trial in a longstanding legal feud involving patents related to hemodialysis...To view the full article, register now.
Already a subscriber? Click here to view full article